APA (7th ed.) Citation

Roby, D. A., Ruiz, F., Kermath, B. A., Voorhees, J. R., Niehoff, M., Zhang, J., . . . Burris, T. P. (2019). Pharmacological activation of the nuclear receptor REV-ERB reverses cognitive deficits and reduces amyloid-β burden in a mouse model of Alzheimer’s disease. PLoS ONE, 14(4), 1. https://doi.org/10.1371/journal.pone.0215004

Chicago Style (17th ed.) Citation

Roby, Deborah A., et al. "Pharmacological Activation of the Nuclear Receptor REV-ERB Reverses Cognitive Deficits and Reduces Amyloid-β Burden in a Mouse Model of Alzheimer’s Disease." PLoS ONE 14, no. 4 (2019): 1. https://doi.org/10.1371/journal.pone.0215004.

MLA (9th ed.) Citation

Roby, Deborah A., et al. "Pharmacological Activation of the Nuclear Receptor REV-ERB Reverses Cognitive Deficits and Reduces Amyloid-β Burden in a Mouse Model of Alzheimer’s Disease." PLoS ONE, vol. 14, no. 4, 2019, p. 1, https://doi.org/10.1371/journal.pone.0215004.